Treating Type 2 Diabetes With Early, Intensive, Multimodal Pharmacotherapy: Real-World Evidence From an International Collaborative Database
Conclusions: In this real-world study, early, intensive polytherapy, targeting the distinct pathophysiological defects in T2D, is associated with significantly more favourable cardiorenal outcomes, compared to insulin and SU therapy.
Saved in:
| Main Authors: | Matthew Anson, Ayesha Malik, Sizheng S. Zhao, Philip Austin, Gema H. Ibarburu, Shabbar Jaffar, Anupam Garrib, Daniel J. Cuthbertson, Uazman Alam |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/2024/3470654 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevalence of microvascular and macrovascular complications of diabetes in newly diagnosed type 2 diabetes in low-and-middle-income countries: A systematic review and meta-analysis.
by: Faith Aikaeli, et al.
Published: (2022-01-01) -
A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX
by: Ralf J. Ludwig, et al.
Published: (2025-03-01) -
Correction: The chemoprotective effect of anti-platelet agents on cancer incidence in people with non-alcoholic fatty liver disease (NAFLD): a retrospective cohort study
by: Matthew Anson, et al.
Published: (2025-03-01) -
The chemoprotective effect of anti-platelet agents on cancer incidence in people with non-alcoholic fatty liver disease (NAFLD): a retrospective cohort study
by: Matthew Anson, et al.
Published: (2024-12-01) -
Effects of hormone replacement therapy (HRT) in midlife women with type 2 diabetes: a retrospective cohort study
by: Matthew Anson, et al.
Published: (2025-07-01)